A MAOA gene*cocaine severity interaction on impulsivity and neuropsychological measures of orbitofrontal dysfunction: Preliminary results

Drug and Alcohol Dependence

Volumn 133, Issue 1, 2013, Pages 287-290

  Verdejo García, Antonio ^a,b   Albein Urios, Natalia ^a   Molina, Esther ^a   Ching López, Ana ^a   Martínez González, José M ^c   Gutiérrez, Blanca ^a,d  

^a UNIVERSITY OF GRANADA   (Spain)

^b MONASH UNIVERSITY   (Australia)

^c Centro Provincial de Drogodependencias   (Spain)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cocaine; Emotion recognition; Lack of Premeditation; MAOA gene; Positive Urgency; Sensation Seeking

Indexed keywords

ADULT; ARTICLE; BRAIN FUNCTION; BRAIN REGION; COCAINE DEPENDENCE; CONTROLLED STUDY; DECISION MAKING; DISEASE ASSOCIATION; DISEASE SEVERITY; EKMAN TEST; EMOTIONALITY; GENE; GENE IDENTIFICATION; GENE INTERACTION; GENETIC CORRELATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HUMAN; IMPULSIVENESS; IOWA GAMBLING TASK SCORE; MAJOR CLINICAL STUDY; MALE; MAOA GENE; NEUROLOGIC DISEASE; NEUROPSYCHOLOGICAL TEST; ORBITAL CORTEX; ORBITOFRONTAL DYSFUNCTION; PATHOLOGICAL GAMBLING; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; TASK PERFORMANCE; UPPS P SCALE; ADOLESCENT; AGE; CASE CONTROL STUDY; COMPLICATION; FACIAL EXPRESSION; FRONTAL LOBE; GAMBLING; GENETICS; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGY; RECOGNITION; SEVERITY OF ILLNESS INDEX; EMOTION RECOGNITION; LACK OF PREMEDITATION; POSITIVE URGENCY; PSYCHOLOGICAL ASPECT; SENSATION SEEKING;

AMINE OXIDASE (FLAVIN CONTAINING); MONOAMINE OXIDASE A, HUMAN; COCAINE;

ADOLESCENT; ADULT; AGE FACTORS; CASE-CONTROL STUDIES; COCAINE-RELATED DISORDERS; DECISION MAKING; FACIAL EXPRESSION; FRONTAL LOBE; GAMBLING; GENOTYPE; HUMANS; IMPULSIVE BEHAVIOR; MALE; MIDDLE AGED; MONOAMINE OXIDASE; NEUROPSYCHOLOGICAL TESTS; RECOGNITION (PSYCHOLOGY); SEVERITY OF ILLNESS INDEX;

COCAINE; EMOTION RECOGNITION; LACK OF PREMEDITATION; MAOA GENE; POSITIVE URGENCY; SENSATION SEEKING;

EID: 84884415555     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2013.04.031     Document Type: Article

References (29)

1. Alia-Klein N., Parvaz M.A., Woicik P.A., Konova A.B., Maloney T., Shumay E., Wang R., Telang F., Biegon A., Wang G.J., Fowler J.S., Tomasi D., Volkow N.D., Goldstein R.Z. Gene x disease interaction on orbitofrontal gray matter in cocaine addiction. Arch. Gen. Psychiatry 2011, 68:283-294.
2. Baggio H.C., Segura B., Ibarretxe-Bilbao N., Valldeoriola F., Marti M.J., Compta Y., Tolosa E., Junque C. Structural correlates of facial emotion recognition deficits in Parkinson's disease patients. Neuropsychologia 2009, 50:2121-2128.
3. Bechara A., Damasio H., Tranel D., Damasio A.R. Deciding advantageously before knowing the advantageous strategy. Science 1997, 275:1293-1295.
4. Bechara A., Tranel D., Damasio H. Characterization of the decision-making deficit of patients with ventromedial prefrontal cortex lesions. Brain 2000, 123:2189-2202.
5. Berlin H.A., Rolls E.T., Kischka U. Impulsivity, time perception, emotion and reinforcement sensitivity in patients with orbitofrontal cortex lesions. Brain 2004, 127:1108-1126.
6. Brunner H.G., Nelen M., Breakefield X.O., Ropers H.H., van Oost B.A. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase, A. Science 1993, 262:578-580.
7. Conners C.K. Clinical use of rating scales in diagnoses and treatment of attention deficit-hyperactivity disorder. Pediatr. Clin. North Am. 1999, 46:857-870.
8. Deckert J., Catalano M., Syagailo Y.V., Bosi M., Okladnova O., Di Bella D., Nothen M.M., Maffei P., Franke P., Fritze J., Maier W., Propping P., Beckmann H., Bellodi L., Lesch K.P. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum. Mol. Genet. 1999, 8:621-624.
9. Epstein D.H., Willner-Reid J., Vahabzadeh M., Mezghanni M., Lin J.L., Preston K.L. Real-time electronic diary reports of cue exposure and mood in the hours before cocaine and heroin craving and use. Arch. Gen. Psychiatry 2009, 66:88-94.
10. Erdfelder E., Faul F., Buchner A. GPOWER: a general power analysis 551 program. Behav. Res. Methods Instrum. Comput. 1996, 28(55):1-11.
11. Fellows L.K. Orbitofrontal contributions to value-based decision making: evidence from humans with frontal lobe damage. Ann. N.Y. Acad. Sci. 2011, 1239:51-58.
12. Fellows L.K., Farah M.J. Different underlying impairments in decision-making following ventromedial and dorsolateral frontal lobe damage in humans. Cereb. Cortex 2005, 15:58-63.
13. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID I) 1997, Biometric Research Department, New York.
14. Good C.D., Lawrence K., Thomas N.S., Price C.J., Ashburner J., Friston K.J., Frackowiak R.S., Oreland L., Skuse D.H. Dosage-sensitive X-linked locus influences the development of amygdala and orbitofrontal cortex, and fear recognition in humans. Brain 2003, 126:2431-2446.
15. Goldstein R.Z., Volkow N.D. Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat. Rev. Neurosci. 2011, 12:652-669.
16. Gutierrez B., Arias B., Gasto C., Catalan R., Papiol S., Pintor L., Fananas L. Association analysis between a functional polymorphism in the monoamine oxidase A gene promoter and severe mood disorders. Psychiatr. Genet. 2004, 14:203-208.
17. Huang Y.Y., Cate S.P., Battistuzzi C., Oquendo M.A., Brent D., Mann J.J. An association between a functional polymorphism in the monoamine oxidase a gene promoter, impulsive traits and early abuse experiences. Neuropsychopharmacology 2004, 29:1498-1505.
18. Ibarretxe-Bilbao N., Junque C., Tolosa E., Marti M.J., Valldeoriola F., Bargallo N., Zarei M. Neuroanatomical correlates of impaired decision-making and facial emotion recognition in early Parkinson's disease. Eur. J. Neurosci. 2009, 30:1162-1171.
19. Kaufman A.S., Kaufman N.L. Kaufman Brief Intelligence Test. 1 1990, American Guidance Service, Circle Pines, MN.
20. Lucantonio F., Stalnaker T.A., Shaham Y., Niv Y., Schoenbaum G. The impact of orbitofrontal dysfunction on cocaine addiction. Nat. Neurosci. 2012, 15:358-366.
21. Matsuo K., Nicoletti M., Nemoto K., Hatch J.P., Peluso M.A., Nery F.G., Soares J.C. A voxel-based morphometry study of frontal gray matter correlates of impulsivity. Hum. Brain Mapp. 2009, 30(4):1188-1195. 10.1002/hbm.20588.
22. O'Doherty J., Critchley H., Deichmann R., Dolan R.J. Dissociating valence of outcome from behavioral control in human orbital and ventral prefrontal cortices. J. Neurosci. 2003, 23:7931-7939.
23. Robinson A.R., Nestler E.J. Transcriptional and epigenetic mechanisms of addiction. Nat. Rev. Neurosci. 2011, 12:623-637.
24. Schulze T.G., Muller D.J., Krauss H., Scherk H., Ohlraun S., Syagailo Y.V., Windemuth C., Neidt H., Grassle M., Papassotiropoulos A., Heun R., Nothen M.M., Maier W., Lesch K.P., Rietschel M. Association between a functional polymorphism in the monoamine oxidase A gene promoter and major depressive disorder. Am. J. Med. Genet. 2000, 96:801-803.
25. Tsuchida A., Fellows L.K. Are you upset? Distinct roles for orbitofrontal and lateral prefrontal cortex in detecting and distinguishing facial expressions of emotion. Cereb. Cortex 2012, 22:2904-2912.
26. Verdejo-Garcia A.J., Lopez-Torrecillas F., Aguilar de Arcos F., Perez-Garcia M. Differential effects of MDMA cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: a multiple regression analysis. Addict. Behav. 2005, 30:89-101.
27. Whiteside S.P., Lynam D.R. The five factor model and impulsivity: using a structural model of personality to understand impulsivity. Pers. Individ. Dif. 2001, 30:669-689.
28. Young A.W., Perrett D.I., Calder A.J., Sprengelmeyer R., Ekman P. Facial Expressions of Emotion: Stimuli and Tests (FEEST) 2002, ThamesValley Test Company, Bury, St. Edmunds.
29. Zald D.H., Andreotti C. Neuropsychological assessment of the orbital and ventromedial prefrontal cortex. Neuropsychologia 2010, 48:3377-3391.